1.95

0.00% 0.00

Pre-market: 1.91 -0.04 -2.05%

Bluejay Diagnostics Inc (BJDX)

Overview News Price History Financials Why BJDX Down? Discussions Forecast Stock Split

Bluejay Diagnostics Inc stock is traded at $1.95, with a volume of 42,084. It is up +0.00% in the last 24 hours and down -40.00% over the past month. Bluejay Diagnostics Inc is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay's first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from 'sample-to-result' to help medical professionals make earlier and better triage/treatment decisions.

Previous Close:

$1.95

Open:

$1.9749

24h Volume:

42,084

Relative Volume:

0.25

Market Cap:

$1.90M

Revenue:

Net Income/Loss:

$-8.59M

P/E Ratio:

-0.00142

EPS:

-1373

Net Cash Flow:

$-9.25M

1W Performance:

-3.94%

1M Performance:

-40.00%

6M Performance:

-65.43%

1Y Performance:

-87.44%

1-Day Range:

$1.8706

$1.9998

1-Week Range:

$1.80

$2.09

52-Week Range:

$1.78

$40.80

Bluejay Diagnostics Inc Stock (BJDX) Company Profile

Name

Bluejay Diagnostics Inc

Sector

Healthcare (1106)

Industry

Medical Devices (138)

Phone

(978) 631-0152

Address

360 MASSACHUSETTS AVENUE, SUITE 203, ACTON

Employee

Twitter

Next Earnings Date

Latest SEC Filings

BJDX's Discussions on Twitter

Compare BJDX vs ABT, SYK, MDT, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
BJDX Bluejay Diagnostics Inc	1.95	1.90M	0	-8.59M	-9.25M	-1,373.00
ABT Abbott Laboratories	113.10	197.42B	44.33B	6.50B	7.40B	3.717
SYK Stryker Corp	381.89	147.18B	25.12B	3.25B	4.28B	8.3984
MDT Medtronic Plc	95.60	124.16B	35.48B	4.64B	5.41B	3.582
BSX Boston Scientific Corp	72.21	109.58B	20.08B	2.89B	3.66B	1.9391
EW Edwards Lifesciences Corp	85.22	49.49B	6.07B	1.06B	1.34B	1.8063

Bluejay Diagnostics Inc Stock (BJDX) Latest News

Mar 02, 2026

Why is Bluejay Diagnostics Inc. stock going downWeekly Trade Summary & Reliable Momentum Entry Alerts - mfd.ru

Feb 21, 2026

Feb 20, 2026

Bluejay Diagnostics Completes Warrant Exercises, Clarifies Capital Structure - TipRanks

Feb 20, 2026

Bluejay Diagnostics says all prefunded warrants exercised; ~972,000 shares outstanding, 1.5M cash-exercise warrants - TradingView

Feb 20, 2026

Bluejay Diagnostics’ Clinical Study Marks Key Transition from Enrollment to Data Analysis - StocksToTrade

Feb 20, 2026

Prefunded warrants fully exercised at Bluejay Diagnostics (NASDAQ: BJDX) - Stock Titan

Feb 20, 2026

Bluejay Diagnostics completes prefunded warrant exercises By Investing.com - Investing.com Canada

Feb 20, 2026

Bluejay Diagnostics Announces Full Exercise of Prefunded Warrants and Current Share Structure Update - Quiver Quantitative

Feb 20, 2026

Bluejay Diagnostics Announces All Prefunded Warrants Now Exercised - marketscreener.com

Feb 20, 2026

Medical diagnostics firm ends prefunded warrants, flags 13G share confusion - Stock Titan

Feb 20, 2026

Feb 19, 2026

Why Etsy Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket - Benzinga

Feb 19, 2026

Feb 18, 2026

Bluejay Advances SYMON II Sepsis Study and Manufacturing - TipRanks

Feb 18, 2026

Bluejay Diagnostics enrolls 545 patients in SYMON II study - TipRanks

Feb 18, 2026

Feb 17, 2026

Bluejay Diagnostics successfully enrolls 545 patients in Symon(TM) II study and advances manufacturing readiness into 2026 - marketscreener.com

Feb 17, 2026

Bluejay Diagnostics Successfully Enrolls 545 Patients in SYMON™ II Study and Advances Manufacturing Readiness into 2026 - The Manila Times

Feb 17, 2026

Bluejay Diagnostics Successfully Enrolls 545 Patients in SYMON II Study and Advances Manufacturing Readiness into 2026 - Bitget

Feb 17, 2026

Bluejay Diagnostics Successfully Enrolls 545 Patients In Symon™ Ii Study And Advances Manufacturing Readiness Into 2026 - TradingView

Feb 17, 2026

Bluejay Diagnostics, Inc. Successfully Enrolls 545 Patients in SYMON?? II Study and Advances Manufacturing Readiness into 2026 - marketscreener.com

Feb 17, 2026

Is Bluejay Diagnostics Inc. stock a smart retirement pickTrade Exit Summary & Entry Point Confirmation Signals - mfd.ru

Feb 17, 2026

Feb 16, 2026

Bluejay Diagnostics, Inc. (NASDAQ:BJDX) Sees Large Increase in Short Interest - Defense World

Feb 16, 2026

Feb 15, 2026

Block Trades: How does Bluejay Diagnostics Inc score in quality rankings2025 Key Highlights & AI Driven Price Predictions - baoquankhu1.vn

Feb 15, 2026

Feb 13, 2026